Enzalutamide versus Bicalutamide in castration-resistant prostate cancer: The STRIVE Trial

June 19, 2018

TUCC physician, Lawrence Karsh, M.D., was a lead principal investigator in this international clinical trial, published in The Journal of Clinical Oncology in January 2016.

Read Article